{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T16:59:36Z","timestamp":1792083576850,"version":"4.4.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2027,2]]},"DOI":"10.1016\/j.cca.2026.121283","type":"journal-article","created":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T14:50:31Z","timestamp":1786805431000},"page":"121283","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Longitudinal automated lipid target monitoring integrated into a laboratory-based clinical decision support system: a real-world cardiovascular risk management approach"],"prefix":"10.1016","volume":"593","author":[{"given":"Jordi","family":"Tortosa-Carreres","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f3nica","family":"Piqueras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Va\u00f1\u00f3-Bellver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Domingo-Valero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenia","family":"Avelino-Hidalgo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Claramunt-Carbonell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu\u00eds","family":"Mart\u00ednez-Dolz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bego\u00f1a","family":"Laiz-Marro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2026.121283_bb0005","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/ehjqcco\/qcz065","article-title":"European Society of Cardiology: cardiovascular disease statistics 2019 (executive summary)","volume":"6","author":"Timmis","year":"2020","journal-title":"Eur. Heart J. Qual. Care Clin. Outcomes"},{"issue":"38","key":"10.1016\/j.cca.2026.121283_bb0010","doi-asserted-by":"crossref","first-page":"4019","DOI":"10.1093\/eurheartj\/ehae466","article-title":"European Society of Cardiology: the 2023 atlas of cardiovascular disease statistics","volume":"45","author":"Timmis","year":"2024","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.cca.2026.121283_bb0015","author":"Instituto Nacional de Estad\u00edstica (INE)"},{"issue":"32","key":"10.1016\/j.cca.2026.121283_bb0020","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1093\/eurheartj\/ehx144","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel","volume":"38","author":"Ference","year":"2017","journal-title":"Eur. Heart J."},{"issue":"1","key":"10.1016\/j.cca.2026.121283_bb0025","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2020","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.cca.2026.121283_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2025.120479","article-title":"2025 Focused update of the 2019 ESC\/EAS guidelines for the management of dyslipidaemias","author":"Mach","year":"2025","journal-title":"Atherosclerosis"},{"issue":"34","key":"10.1016\/j.cca.2026.121283_bb0035","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","article-title":"2021 ESC guidelines on cardiovascular disease prevention in clinical practice","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur. Heart J."},{"issue":"4","key":"10.1016\/j.cca.2026.121283_bb0040","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2025-114031","article-title":"Real-world changes in lipid-lowering therapy use and LDL-C goal attainment in high and very high cardiovascular risk patients in the UK: a secondary analysis of the European SANTORINI study 1-year follow-up","volume":"16","author":"Connolly","year":"2026","journal-title":"BMJ Open"},{"issue":"8","key":"10.1016\/j.cca.2026.121283_bb0045","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1177\/2047487318825350","article-title":"Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: results from the European Society of Cardiology ESC-EORP EUROASPIRE V registry","volume":"26","author":"Kotseva","year":"2019","journal-title":"Eur. J. Prev. Cardiol."},{"issue":"8","key":"10.1016\/j.cca.2026.121283_bb0050","article-title":"Usage of lipid-lowering therapies in patients at high and very high cardiovascular risk from Spain: one-year follow-up of the Spanish subpopulation from the European SANTORINI study","volume":"225","author":"Mostaza","year":"2025","journal-title":"Rev. Clin. Esp."},{"issue":"2","key":"10.1016\/j.cca.2026.121283_bb0055","doi-asserted-by":"crossref","DOI":"10.3390\/jcm14020493","article-title":"Therapeutic inertia in dyslipidemia management for secondary cardiovascular prevention: results from the Italian ITACARE-P network","volume":"14","author":"Faggiano","year":"2025","journal-title":"J. Clin. Med."},{"issue":"7","key":"10.1016\/j.cca.2026.121283_bb0060","doi-asserted-by":"crossref","DOI":"10.3390\/jcm14072340","article-title":"Assessing LDL-C levels and lipid-modifying therapies in a real-world cohort of patients with atherosclerotic cardiovascular disease: the REALITY study","volume":"14","author":"Campuzano","year":"2025","journal-title":"J. Clin. Med."},{"issue":"5","key":"10.1016\/j.cca.2026.121283_bb0065","first-page":"219","article-title":"Hypercholesterolaemia control in Spain: the same situation with different regional realities","volume":"35","author":"Pedro-Botet","year":"2023","journal-title":"Clin. Investig. Arterioscler."},{"key":"10.1016\/j.cca.2026.121283_bb0070","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.atherosclerosis.2023.04.013","article-title":"Impact of physician\u2019s perception about LDL cholesterol control in clinical practice when treating patients in Spain","volume":"375","author":"Cos\u00edn-Sales","year":"2023","journal-title":"Atherosclerosis"},{"issue":"5","key":"10.1016\/j.cca.2026.121283_bb0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0272883","article-title":"Low LDL-C goal attainment in patients at very high cardiovascular risk due to lacking observance of the guidelines on dyslipidaemias","volume":"18","author":"Vrabl\u00edk","year":"2023","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.cca.2026.121283_bb0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0286376","article-title":"Trends in low-density lipoprotein cholesterol goal achievement and changes in lipid-lowering therapy after incident atherosclerotic cardiovascular disease: Danish cohort study","volume":"18","author":"Ersb\u00f8ll","year":"2023","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.cca.2026.121283_bb0085","doi-asserted-by":"crossref","first-page":"18936","DOI":"10.1038\/s41598-022-21916-8","article-title":"Medication non-adherence and therapeutic inertia independently contribute to poor disease control for cardiometabolic diseases","volume":"12","author":"Yan","year":"2022","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.cca.2026.121283_bb0090","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1093\/ehjcvp\/pvaf007","article-title":"Expert opinion on the integration of combination therapy into the treatment algorithm for the management of dyslipidaemia: the integration of ezetimibe and bempedoic acid may enhance goal attainment","volume":"11","author":"Parhofer","year":"2025","journal-title":"Eur. Heart J. Cardiovasc. Pharmacother."},{"issue":"9","key":"10.1016\/j.cca.2026.121283_bb0095","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.3390\/jcm12093187","article-title":"Real-world attainment of low-density lipoprotein cholesterol goals in patients at high risk of cardiovascular disease treated with high-intensity statins: the TERESA study","volume":"12","author":"Barrios","year":"2023","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.cca.2026.121283_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinbiochem.2025.110922","article-title":"Advancing cardiovascular risk assessment: real-time SCORES2 calculation through CDSS in primary care patients","volume":"137","author":"Salinas","year":"2025","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.cca.2026.121283_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2026.120943","article-title":"A laboratory-driven clinical decision support system algorithm for personalized and automated cardiovascular risk stratification in primary care patients","volume":"587","author":"Tortosa-Carreres","year":"2026","journal-title":"Clin. Chim. Acta Int. J. Clin. Chem."},{"issue":"17","key":"10.1016\/j.cca.2026.121283_bb0110","doi-asserted-by":"crossref","first-page":"e1154","DOI":"10.1161\/CIR.0000000000001423","article-title":"2026 ACC\/AHA\/AACVPR\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of dyslipidemia: a report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines","volume":"153","author":"Writing Committee Members","year":"2026","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.cca.2026.121283_bb0115","first-page":"91","article-title":"Consensus document for lipid profile determination and reporting in Spanish clinical laboratories. What parameters should be included in a basic lipid profile?","volume":"35","author":"Arrobas Velilla","year":"2023","journal-title":"Clin. Investig. Arterioscler."},{"issue":"9","key":"10.1016\/j.cca.2026.121283_bb0120","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1161\/CIR.0000000000001168","article-title":"2023 AHA\/ACC\/ACCP\/ASPC\/NLA\/PCNA guideline for the management of patients with chronic coronary disease: a report of the American Heart Association\/American College of Cardiology joint committee on clinical practice guidelines","volume":"148","author":"Virani","year":"2023","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.cca.2026.121283_bb0125","first-page":"e596","article-title":"2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines","volume":"140","author":"Arnett","year":"2019","journal-title":"Circulation"},{"issue":"24","key":"10.1016\/j.cca.2026.121283_bb0130","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1161\/CIR.0000000000001191","article-title":"Novel prediction equations for absolute risk assessment of total cardiovascular disease incorporating cardiovascular-kidney-metabolic health: a scientific statement from the American Heart Association","volume":"148","author":"Khan","year":"2023","journal-title":"Circulation"},{"issue":"4S","key":"10.1016\/j.cca.2026.121283_bb0135","first-page":"S117","article-title":"KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"105","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group","year":"2024","journal-title":"Kidney Int."},{"issue":"4","key":"10.1016\/j.cca.2026.121283_bb0140","doi-asserted-by":"crossref","DOI":"10.1002\/jgh3.13061","article-title":"Hypertriglyceridemia-induced acute necrotizing pancreatitis: poor clinical outcomes requiring revisiting management modalities","volume":"8","author":"Abboud","year":"2024","journal-title":"JGH Open"},{"issue":"9","key":"10.1016\/j.cca.2026.121283_bb0145","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.jacc.2021.06.011","article-title":"2021 ACC expert consensus decision pathway on the management of ASCVD risk reduction in patients with persistent hypertriglyceridemia: a report of the American College of Cardiology solution set oversight committee","volume":"78","author":"Virani","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"issue":"5","key":"10.1016\/j.cca.2026.121283_bb0150","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.amepre.2015.04.006","article-title":"Clinical decision support systems and prevention: a community guide cardiovascular disease systematic review","volume":"49","author":"Njie","year":"2015","journal-title":"Am. J. Prev. Med."},{"key":"10.1016\/j.cca.2026.121283_bb0155","article-title":"Computerised clinical decision support systems and absolute improvements in care: meta-analysis of controlled clinical trials","volume":"370","author":"Kwan","year":"2020","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.cca.2026.121283_bb0160","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.46519","article-title":"Effect of clinical decision support at community health centers on the risk of cardiovascular disease: a cluster randomized clinical trial","volume":"5","author":"Gold","year":"2022","journal-title":"JAMA Netw. Open"},{"issue":"2","key":"10.1016\/j.cca.2026.121283_bb0165","doi-asserted-by":"crossref","DOI":"10.1177\/14604582211007536","article-title":"The appropriateness of clinical decision support systems alerts in supporting clinical workflows: a systematic review","volume":"27","author":"Olakotan","year":"2021","journal-title":"Health Inform. J."},{"issue":"2","key":"10.1016\/j.cca.2026.121283_bb0170","doi-asserted-by":"crossref","DOI":"10.2196\/12469","article-title":"Interruptive versus noninterruptive clinical decision support: usability study","volume":"6","author":"Blecker","year":"2019","journal-title":"JMIR Hum. Factors"},{"key":"10.1016\/j.cca.2026.121283_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajpc.2024.100855","article-title":"Do clinical decision support tools improve quality of care outcomes in the primary prevention of cardiovascular disease: a systematic review and meta-analysis","volume":"20","author":"Buzancic","year":"2024","journal-title":"Am. J. Prev. Cardiol."},{"issue":"1","key":"10.1016\/j.cca.2026.121283_bb0180","article-title":"Physicians\u2019 misperceived cardiovascular risk and therapeutic inertia as determinants of low LDL-cholesterol targets achievement in diabetes","volume":"21","author":"Morieri","year":"2022","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.cca.2026.121283_bb0185","article-title":"Real-world characterization of clinical management and achievement of the recommended risk-based low-density lipoprotein cholesterol and blood pressure goals in patients with arterial hypertension and dyslipidemia. The SNAPSHOT study","volume":"38","author":"Mostaza","year":"2026","journal-title":"Clin. Invest. Arterioscler. Engl. Ed."},{"issue":"11","key":"10.1016\/j.cca.2026.121283_bb0190","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1093\/eurjpc\/zwaa047","article-title":"EU-wide cross-sectional observational study of lipid-modifying therapy use in secondary and primary care: the DA VINCI study","volume":"28","author":"Ray","year":"2021","journal-title":"Eur. J. Prev. Cardiol."},{"key":"10.1016\/j.cca.2026.121283_bb0195","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.diabres.2017.12.004","article-title":"Achievement of guideline targets for blood pressure, lipid, and glycaemic control in type 2 diabetes: a meta-analysis","volume":"137","author":"Khunti","year":"2018","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"7","key":"10.1016\/j.cca.2026.121283_bb0200","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.ejim.2006.03.005","article-title":"Primary prevention in high-risk dyslipidemic patients without an established cardiovascular disease: undertreatment and rationale for lipid-lowering therapy","volume":"17","author":"Zafrir","year":"2006","journal-title":"Eur. J. Intern. Med."},{"issue":"1","key":"10.1016\/j.cca.2026.121283_bb0205","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1370\/afm.2908","article-title":"Barriers and facilitators to the use of clinical decision support systems in primary care: a mixed-methods systematic review","volume":"21","author":"Meunier","year":"2023","journal-title":"Ann. Fam. Med."},{"issue":"03","key":"10.1016\/j.cca.2026.121283_bb0210","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1055\/s-0042-1748856","article-title":"Clinical decision support stewardship: best practices and techniques to monitor and improve interruptive alerts","volume":"13","author":"Chaparro","year":"2022","journal-title":"Appl. Clin. Inform."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898126004651?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898126004651?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T16:31:07Z","timestamp":1792081867000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898126004651"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,2]]},"references-count":42,"alternative-id":["S0009898126004651"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2026.121283","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2027,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Longitudinal automated lipid target monitoring integrated into a laboratory-based clinical decision support system: a real-world cardiovascular risk management approach","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2026.121283","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"121283"}}